Quantapore

Biotechnology, Health Care, Medical
Founded in 2009-01-01
Menlo Park, California, United States
http://www.quantapore.com/
For Profit

About Quantapore

Quantapore is a biotech company developing nanopore-based nucleic acid sequencing technology. Unlike other nanopore approaches, Quantapore utilizes an optical read out which results in lower cost and higher throughput compared to electrical data acquisition. Its novel proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The quantum-optic interaction between the nanopore and the DNA allows for single molecule nucleic acid sequencing at an unprecedented speed and cost. Quantapore was founded by Sascha C. Dennstedt and Martin Huber in 2009.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: 550
  • Tech Stack: 10 active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 52000000 USD
  • Last Funding: 17000000 USD (Series C)
  • Funding Status: Late Stage Venture

Technology Stack

Quantapore actively uses 10 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Medical

Headquarters: Menlo Park, California, United States